CoChat

Projecting the long‐term societal value of a disease‐modifying treatment for Alzheimer's disease in the United States

Open access
Prados, Maria J., Liu, Ying, Jun, Hankyung, Lam, Jenny, Mattke, Soeren · 2022 · Alzheimer's & Dementia
Cited by 42

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Introduction: We estimate societal value of a disease‐modifying Alzheimer's disease (AD) treatment that reduces progression by 30% in early stages. Methods: Using the International Society for Pharmacoeconomics and Outcomes Research value flower as framework, we estimate gross societal value, that is, not including treatment cost, from avoided medical and social care costs, productivity and quality‐adjusted life‐years (QALY) gains for patients and caregivers, adjusting for severity of disease, value of financial insurance, and value of insurance for currently unafflicted adults with a Markov model. Results: Predicted societal value from 2021 until 2041 is $2.62 trillion for the overall afflicted US population and $986 billion for the 2021 prevalent cohort or $134,418 per person, with valuation of patients’ QALY gains (63%) and avoided nursing‐home costs (20%) as largest components. Delays in access because of health system capacity constraints could reduce realized value between 52% and 69%. The value of insurance for the unafflicted is $4.52 trillion or $18,399 on average per person. Discussion: With a total of $5.5 trillion, the projected gross societal value of a hypothetical AD treatment is substantial, which may help to put the cost of treatment into perspective.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/alz.12578

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 42

Metadata

Authors
Prados, M. J., Liu, Y., Jun, H., Lam, J., & Mattke, S.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2022-01
Volume
18
Issue
1
Pages
142-151
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W4211104519
Cited by
42
References
13
FWCI
6.52
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Projecting the long‐term societal value of a disease‐modifying treatment for Alzheimer's disease in the United States. https://app.cochat.ai/papers/10.1002/alz.12578
The paper
Prados, M. J., Liu, Y., Jun, H., Lam, J., & Mattke, S. (2022). Projecting the long‐term societal value of a disease‐modifying treatment for Alzheimer's disease in the United States. Alzheimer's & Dementia. https://doi.org/10.1002/alz.12578

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.